series-c-plus
Stage
1
Investors
About
Capricor Therapeutics is a clinical-stage biotechnology company developing cell- and exosome-based therapies focused on treating cardiac and muscular diseases such as Duchenne muscular dystrophy.
Explore Capricor Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.